Spinal Elements’ Lotus System gets FDA clearance for new indication: 5 key notes

Spinal Elements received FDA clearance to market the Lotus Posterior Cerivcal/Thoracic Spinal System with expanded indications for posterior cervical screw placement.

Advertisement

Here are five key notes:

 

1. The previous clearances allowed only thoracic (T1-T3) spine placement. Surgeons can now place screws in the cervical (C1-C7) spine.

 

2. The new indication makes Spinal Elements one of three companies in the posterior cervical-thoracic space to achieve expanded indication clearance.

 

3. The Lotus system is intended to provide immobilization and stabilization of spinal segments as an adjunct to fusion. It can be used in instability, deformity, failed fusion, tumors and degenerative cases.

 

4. The system was also designed to restore the spinal column’s integrity even without fusion for a limited time period in patients with advanced stage tumors involving the cervical spine if life expectancy is an insufficient duration to permit fusion.

 

5. Lotus can connect to the Mercury Spinal System for different diameter transition rods.

 

More articles on orthopedic devices:
5 observations on Amedica shares dropping by 15.92%
Global MIS market to grow to $50B+ by 2019: 7 key trends
ExactechGPS launches globally: 5 things to know

At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.